14天12板，停牌核查！

Core Viewpoint - The stock of HeFu China has experienced a significant increase, prompting the company to apply for a trading suspension to protect investors' interests due to abnormal trading behavior and a substantial deviation from its fundamental performance [2][4][6]. Stock Performance - On November 14, HeFu China's stock closed at 23.8 yuan per share, with a closing increase of 7.69% [2]. - From October 28 to November 14, the stock price surged by 256.29%, with 12 out of 14 trading days closing at the daily limit price [6][10]. - The stock's trading volume reached a high turnover rate of 28.48% on November 14 [2]. Trading Suspension - HeFu China announced that its stock would be suspended from trading starting November 17, with an expected suspension period of no more than three trading days [2][6]. - The company has indicated that the stock price has significantly deviated from its fundamentals, raising concerns about potential irrational market behavior [6][10]. Financial Performance - For the first three quarters of 2025, HeFu China reported a revenue of 549 million yuan, a year-on-year decrease of 22.80% [10]. - The net profit attributable to shareholders was -12.39 million yuan, down 146.65% year-on-year, with the third quarter showing a net profit of -5.05 million yuan, a decline of 225.26% [10]. - The decline in performance is attributed to reduced procurement prices for products aimed at hospital clients and a decrease in order volumes compared to the previous year [10].